Yunha Noh is currently an undergraduate research student at CCADD, following her successful completion of the 2023 Winter Internship Program. She has received dual Bachelor’s degrees in Biotechnology and Computer Engineering from Duksung Women's University. Her primary research interests include applying machine learning to drug repurposing and leveraging real world data (RWD) to real world evidence in medical science.

On February 26th, Professor Howard and the CCADD members gathered to honor the graduation of Tae Kyu Chung and the successful completion of the winter internship program by Seorin Choi and Yunha Noh.

Tae Kyu, who studied the realm of biology-neurobiology as an undergrad, joined CCADD in February 2018 as an intern. Under the guidance of Professor Howard Lee thenceforth, he navigated through the rigors of an integrated master's and PhD program. His persistent dedication to PKPD modeling culminated in a doctoral thesis entitled “Comparison of Machine Learning and Population Pharmacokinetic Models for Predicting Antiepileptic Drug Concentrations Based on Therapeutic Drug Monitoring Records”, earning him a Doctor of Medicine degree. On the graduation day, his relentless pursuit was duly awarded.

Simultaneously, a ceremony to mark the completion of Seorin and Yunha's internship was conducted at the main campus of Seoul National University. Throughout their internship, they immersed themselves in a series of educational endeavors, presentations, and assignments. On that day, their efforts, all contained within a comprehensive poster presentation, were met with a deep appreciation. Members of CCADD also attended the ceremony to celebrate the completion of their internships.

As we congratulate their accomplishments, we also look forward with anticipation to their future as independent researchers.

The study "Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus," authored by Yesol Hong, Yoomin Jeon, Yoona Choi, Tae Kyu Chung, and Howard Lee, was published in the Diabetes Therapy on December 20, 2023. Conducted at Seoul National University Hospital (SNUH) in South Korea, this research by the CCADD team delved into the use of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in Type 2 Diabetes Mellitus (T2DM) treatment. The study, utilizing Real-World Data (RWD) from electronic medical records (EMR) from SNUH's a Common Data Model database, revealed improvements in HbA1c levels and a higher rate of patients achieving targeted HbA1c levels with SGLT2i therapy.

Furthermore, CCADD is dedicated to continuing its use of EMR-based RWD to generate important clinical evidence, particularly in areas where Randomized Controlled Trials (RCTs) may face limitations. This commitment underscores CCADD's role in advancing medical research and improving patient care through innovative data utilization.

We are thrilled to declare that the unwavering dedication of our research team, led by Yoomin Jeon under Prof.Howard Lee's supervision has culminated in the successful approval of the first patent by CCADD!

This patent covers our novel machine learning-based dimensionality reduction model designed to revolutionize the assessment of clinical trial feasibility. By leveraging electronic medical records to identify common sensitive eligibility features, the research team aimed to significantly improve the efficiency and precision of clinical trial feasibility assessment. This accomplishment not only marks a significant milestone of our research project, but also paves the way for enhanced clinical trial practices in the future.

On December 27th, 2023, CCADD held the year-end workshop at Front1, a startup hub at the heart of Seoul, where PMACH is based. This year, Prof. Howard Lee and the members of CCADD were joined by PMATCH and Dr. Siun Kim. The workshop went on in a dynamic atmosphere, welcoming both Prof. Howard’s part-time student and the interns for the upcoming internship program.

After a brief ice-breaking time, the main session started with a recap of the accomplishments of 2023, reflecting on the overall trajectory. Prof. Howard commended CCADD’s continuous growth in both research and publications. As preparation for 2024, the following session outlined a roadmap, encompassing detailed research ideas and plans for conference to attend in 2024.

The spotlight then turned to CCADD interns. Three passionate interns—Tang Chao, Seorin Choi, and Yunha Noh—who will join the 2024 winter internship program introduced themselves through "Who am I" presentations. Following this, Yujin expressed her aspirations for the path ahead as a new CCADD graduate research student. The workshop proceeded with a lecture on the challenges faced by postdoctoral researchers and strategies for maintaining a healthy mindset among graduate students.

Dr. Siun Kim took a special session to share insights into his post-doctoral journey following graduation. Delivering a lecture on the trending topic of "LLMs in medicine and drug development", he provided valuable perspectives and briefly introduced his ongoing research projects. He candidly shared reflections on the first-year post doc., emphasizing the professional commitment required in the field of research.

Finally, PMATCH summarized their achievements in 2023 and anticipated the upcoming year's developments. With the successful launch of the 'BATTERY' app and a triumphant debut at CES^® 2023, PMATCH envisions a promising future with new team members. Yoomin Jeon, the Chief Technology Officer of PMATCH, expressed her commitment to meeting user’s needs as a must-have app.

The workshop concluded with a keynote address by Prof. Howard. Introducing new trends in 2024, he emphasized the significance of adjusting our research focus and domain knowledge to take another leap forward. Prof. Howard’s central message highlighted 2024 as a pivotal year for CCADD's rebound and PMATCH's inaugural year of growth.